Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hojoon Sohn

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
PLOS Global Public Health|April 30, 2025
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, et al.
The Lancet. Global Health|January 20, 2023
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysisRyan R Thompson, Talemwa Nalugwa, Denis Oyuku, et al.
BMC Infectious Diseases|July 2, 2015
Psychological distress and its relationship with non-adherence to TB treatment: a multicentre studyGrant Theron, Jonny Peter, Lynn Zijenah, et al.
Contemporary Clinical Trials|June 21, 2025
Evaluating smoking cessation interventions for people living with HIV in a factorial randomised clinical trial in South Africa using the Multiphase Optimization Strategy (MOST) framework: The Tlogela Trial protocolLeisha P Genade, Laura Steiner, Firdaus Nabeemeeah, et al.
Plos Medicine|November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisAnna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Trials|August 5, 2022
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contactsSamyra R Cox, Abhay Kadam, Sachin Atre, et al.
The Lancet. Global Health|July 2, 2026
Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trialSamyra R Cox, Abhay Kadam, Shahanara Valawalkar, et al.
Implementation Science : IS|November 17, 2022
Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping reviewAkash Malhotra, Ryan R Thompson, Faith Kagoya, et al.
Trials|July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
Scientific Reports|April 30, 2026
Impact of vitamin D deficiency on 6-month culture conversion in nontuberculous mycobacterial pulmonary diseaseTae-Ok Kim, Nakwon Kwak, Doosoo Jeon, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
PLOS Global Public Health|April 30, 2025
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)Akash Malhotra, Ahmed Bedru, Fiseha Mulatu, et al.
The Lancet. Global Health|January 20, 2023
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysisRyan R Thompson, Talemwa Nalugwa, Denis Oyuku, et al.
BMC Infectious Diseases|July 2, 2015
Psychological distress and its relationship with non-adherence to TB treatment: a multicentre studyGrant Theron, Jonny Peter, Lynn Zijenah, et al.
Contemporary Clinical Trials|June 21, 2025
Evaluating smoking cessation interventions for people living with HIV in a factorial randomised clinical trial in South Africa using the Multiphase Optimization Strategy (MOST) framework: The Tlogela Trial protocolLeisha P Genade, Laura Steiner, Firdaus Nabeemeeah, et al.
Plos Medicine|November 17, 2011
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysisAnna Vassall, Sanne van Kampen, Hojoon Sohn, et al.
Trials|August 5, 2022
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contactsSamyra R Cox, Abhay Kadam, Sachin Atre, et al.
The Lancet. Global Health|July 2, 2026
Phone-based screening versus home-based screening after tuberculosis in India (TB Aftermath): a multicentre, open-label, randomised, controlled, non-inferiority trialSamyra R Cox, Abhay Kadam, Shahanara Valawalkar, et al.
Implementation Science : IS|November 17, 2022
Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping reviewAkash Malhotra, Ryan R Thompson, Faith Kagoya, et al.
Trials|July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
Scientific Reports|April 30, 2026
Impact of vitamin D deficiency on 6-month culture conversion in nontuberculous mycobacterial pulmonary diseaseTae-Ok Kim, Nakwon Kwak, Doosoo Jeon, et al.
Pageof 7